title: Reply to Chris R. Cardwell, Samy Suissa and Liam J. Murray's letter to the editor re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007.
authors.forename: Helene Hartvedt
authors.initials: HH
authors.lastname: Grytli
authors.forename: Morten Wang
authors.initials: MW
authors.lastname: Fagerland
authors.forename: Sophie D
authors.initials: SD
authors.lastname: Fosså
authors.forename: Kristin Austlid
authors.initials: KA
authors.lastname: Taskén
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000401:mortality*
chemical_list: D000319:Adrenergic beta-Antagonists